Treatment of systemic and refractory adult-onset still's disease with Tofacitinib. efficacy of JAK/STAT Pathway inhibition
Author | dc.contributor.author | Aguilera, Sergio | |
Author | dc.contributor.author | Rivera, Diego | |
Author | dc.contributor.author | Barrera, María José | |
Admission date | dc.date.accessioned | 2020-06-06T21:11:35Z | |
Available date | dc.date.available | 2020-06-06T21:11:35Z | |
Publication date | dc.date.issued | 2020 | |
Cita de ítem | dc.identifier.citation | JCR: Journal of Clinical Rheumatology. 26(3):19, (2020) | es_ES |
Identifier | dc.identifier.uri | https://repositorio.uchile.cl/handle/2250/175289 | |
Lenguage | dc.language.iso | en | es_ES |
Publisher | dc.publisher | Lippincott Williams & Wilkins | es_ES |
Source | dc.source | JCR: Journal of Clinical Rheumatology | es_ES |
Título | dc.title | Treatment of systemic and refractory adult-onset still's disease with Tofacitinib. efficacy of JAK/STAT Pathway inhibition | es_ES |
Document type | dc.type | Artículo de revista | |
dcterms.accessRights | dcterms.accessRights | Acceso a solo metadatos | es_ES |
Cataloguer | uchile.catalogador | ctc | es_ES |
Indexation | uchile.index | Artículo de publicación ISI | es_ES |
Files in this item
This item appears in the following Collection(s)
-
Artículos de revistas
Artículos de revistas